Annual report pursuant to Section 13 and 15(d)

Statements of Cash Flows

v3.22.1
Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ (5,169) $ 5,762,646
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Change in fair value of derivative warrant liabilities (9,243,640)
Change in fair value of promissory note – related party (144,070)
Loss on promissory note – related party 37,020
Financing costs - derivative warrant liabilities 1,406,506
Income from investments held in Trust Account (49,773)
Changes in operating assets and liabilities:    
Prepaid expenses (774,677)
Accounts payable 4,525 3,523
Accrued expenses (231,066)
Deferred legal fees   957,588
Franchise tax payable 609 199,436
Net cash used in operating activities (35) (2,076,507)
Cash Flows from Investing Activities    
Investment of cash in Trust Account (862,500,000)
Net cash used in investing activities (862,500,000)
Cash Flows from Financing Activities:    
Proceeds from issuance of Class B common stock to Sponsor 25,000
Proceeds from note payable to related party 170,000 2,000
Repayment of note payable to related party (266,099)
Proceeds received from initial public offering, gross 862,500,000
Proceeds from private placement 19,250,000
Offering costs paid (147,875) (17,619,610)
Proceeds from promissory note to related party 1,500,000
Net cash provided by financing activities 47,125 865,366,291
Net change in cash 47,090 789,784
Cash - beginning of the period 47,090
Cash - end of the period 47,090 836,874
Supplemental disclosure of noncash financing activities:    
Offering costs included in accrued expenses 21,614 372,369
Deferred offering costs included in accounts payable 113,386
Offering costs paid by related party under promissory note 94,099
Deferred underwriting commissions $ 30,187,500